News
Though most stakeholders are still drowning in the 455-page meaningful use Stage 2 proposed rule, issued February 23 by the Department of Health and Human Services (HHS), a few groups have stepped forward to weigh in.
After some stops and starts, at last the federal government has released the long-awaited proposal for Stage 2 of qualifying for the meaningful use of electronic health records incentives.
On the third day of the HIMSS12 conference in Las Vegas, Farzad Mostashari, MD, took to the stage in what ended up being a rousing address to a packed room of attendees. Here are seven key highlights from Mostashari's keynote speech.
The results of the health IT incentive program aimed at driving the adoption of electronic health records by hospitals and physicians have been "breathtaking," Farzad Mostashari, MD, asserted in his keynote address at HIMSS12 on Thursday. "We've made more progress in two years than we've made in 20," said Mostashari, national coordinator for health information technology.
Temporary EHR certification program will end with publication of final rule for meaningful use stage 2 in late August, ONC says
HHS sends millions to 10 states to establish health insurances exchanges and says state legislative authority unnecessary to request funds.
In their Views from the Top session, "Mercy Rising in Joplin: How Advanced Planning and Resolve Are Helping Us Rebuild," Lynn Britton, president and CEO, and William Showalter, vice president and CIO, both of Mercy Health, shared their experiences of recovering essential information and services, reestablishing information and workflow and rebuild.
While there has been much talk in healthcare about using information technology on the clinical end to build an interoperable industry, the financial side of healthcare has been given short shrift.
Past president Bonnie Cassidy explains that regardless of the forthcoming new ICD-10 compliance deadline, healthcare organizations need to map out their training efforts and then be sure to retrain those coders, particularly once they've achieved certification.
The super registry would list patient registries in the model of ClinicalTrials.gov, which follows use of new therapies for research.